Category: First Page
Please, enter cell line, author or any other phrase or word you would like to search for.
CEO interview in BioStock
In the article published today by BioStock, the company’s CEO Peter Egelberg comments on the developments during the past autumn.
New CEO commentary: “The Single-Cell Revolution”
PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.
Growing & Analyzing Cells at their Best
BioSpherix and Phase Holographic Imaging (PHI) have teamed up to support researchers in their ambition to grow and analyze cells in a cell-friendly environment, without cell disturbing factors like labels, stains and temperature fluctuations.
New SelectScience eBook helps scientists choose the best cell imaging technology
A new cell imaging technology guide has been launched by leading independent science publisher SelectScience® to help scientists find the best equipment for their applications.
Interim Report 1 2019/20
Interim Report 1 (2019-05-01 – 2019-07-31) from Phase Holographic Imaging.
US National Institutes of Health intends to purchase HoloMonitor
The US National Institute of Aging intends to purchase a HoloMonitor instrument from Phase Holographic Imaging. The National Institute of Aging is part of the National Institutes of Health (NIH), a government agency to promote medical research.
PHI and leading supplier of cell analysis instrumentation sign agreement
Phase Holographic Imaging (PHI) and a major publicly traded international supplier of laboratory equipment and cell analysis instrumentation have entered an agreement aiming to determine the scope and nature of a future partnership. The agreement is a result of discussions between the company management teams, over an extended period time.
PHI establish US subsidiary to foster US partnerships
As part of the ongoing expansion of activities on the US market, the Board of Directors of Phase Holographic Imaging (PHI) has initiated the process of establishing a fully owned subsidiary in the US.
PHI releases App Suite 2 – more apps and greater applicability
App Suite 2 is the second release in a series of planned App Suite releases, developed to provide automated live-cell studies to researchers worldwide in an unprecedented user-friendly workflow, using PHI’s HoloMonitor-technology.
PHI expands European distributor network
System-c bioprocess, Aurogene and Labsoft have recently been appointed to respectively represent Phase Holographic Imaging (PHI) in France, Italy and Poland.
12